Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 December 2020 | Story André Damons | Photo Supplied
Dr Michael Pienaar is a lecturer in the University of the Free State’s (UFS) department of Paediatrics and Child Health.

A lecturer from the University of the Free State’s (UFS) department of Paediatrics and Child Health is investigating the use of artificial neural networks to develop models for the prediction of patient outcomes in children with severe illness.

Dr Michael Pienaar, senior lecturer and specialist, is conducting this research as part of his doctoral research and the study deals primarily with the development of models that are designed and calibrated for use in South Africa. These artificial neural networks are computer programs designed to mimic some of the learning characteristics of biological neurons.

The potential applications of models

According to Dr Pienaar these models have traditionally been developed in high-income nations using conventional statistical methods.

“The potential applications of such models in the clinical setting include triage, medical research, guidance of resource allocation and quality control. Having initially begun this research investigating the prediction of mortality outcomes in the paediatric intensive care unit (PICU) I have broadened my scope to patients outside of PICU, seeking to identify children early during their illnesses who are at risk of serious illness requiring PICU,” says Dr Pienaar.

The research up until now has been directed towards the identification of characteristics that are both unique to children with serious illness in South Africa, but also accessible to clinicians in settings where expertise and technical resources are limited.

Research still in the early changes

The research is still in its early stages but next year a series of expert review panels will be held to investigate the selection of variables for the model, after which the collection of clinical data will begin. Once the data has been collected and prepared, a number of candidate models will be developed and evaluated. This should be concluded by the end of 2022.

Says Dr Pienaar: “The need to engage with the rapid proliferation of technology, particularly in the realms of machine learning, mobile technology, automation and the Internet of Things is as great in medical research now as it is in any academic discipline.

“It is critical that research, particularly in South Africa, engage with this in order to take advantage of the opportunities offered and avoid the dangers that go paired with them. Together with the technology as such, it has been essential to pursue this project as an interdisciplinary undertaking involving clinicians, biostatisticians and computer engineers.”

Hope for the research  

Dr Pienaar says he was very fortunate and grateful to be the recipient of a generous interdisciplinary grant from the UFS which has allowed him to procure software and equipment that is critical to this project.

“The hope for this research is that the best performing of these models can be integrated with a mobile application that assists practitioners in a wide range of settings in the identification, treatment and early referral of children at high risk of severe illness. I would like to expand this research project to include other countries in Africa and South America and to use it as a bridge to collaboration with other clinical researchers in the Global South,” says Dr Pienaar.

As an early career researcher, Dr Pienaar hopes that this research can serve as a platform to build a body of research that uses the rapid technological advances of these times together with a wide range of collaborations with other disciplines in the pursuit of better child health.

He concludes by saying that he has had excellent support thus far from his supervisors, Prof Stephen Brown (Faculty of Health Sciences, UFS), Dr Nicolaas Luwes (Faculty of Computer Science and Engineering, Central University of Technology) and Dr Elizabeth George (Medical Research Council Clinical Trials Unit, University College London). I have also been supported by the Robert Frater Institute in the Faculty of Health Sciences.

News Archive

Arment-My-Nie proved what a time it is to be alive at the 2016 Stagedoor
2016-03-15

Description: 2016 03 KL Stagedoor Tags: Stagedoor

2016 has been nothing short of events that have left students singing the phrase, “What A Time To Be Alive!” This year’s Stagedoor theme had first-year groups re-enacting some of the most memorable times of 2016 and even far into the future.

On 12 March 2016, the show continued with the newly adopted format which was initiated last year, whereby residences are coupled together. With all teams being entered into the finals round, this can be seen as a victory for all, as the crowds of students and parents had the opportunity to see all pairs perform.

Kovsie Church, on the Bloemfontein Campus of the University of the Free State, was packed wall-to-wall with fans and supporters who were high in anticipation of the never-seen-before performances. This resulted in even more excitement for audiences and a tight competition for the residences.

With the theme already set out, the show began to roll, and audiences were enticed with each performance. Audiences experienced the tongue-in-cheek wit of performers, as many scripts had underlying references which left viewers roaring with laughter.

Only three groups could, however, walk away with the top spots. Karee and Arista were third, with Sonnedou and Villa Bravado coming out second, and the trophy was taken by Armentum and Vergeet-My-Nie.

This year, the Arts and Culture office of the Student Representative Council introduced additional categories to the competition. The winners were:

  • McDonalds Jingle – Legatum and NJ van der Merwe

  • Best Actor – Bernie Neser

  • Best Actress – Maynie Knoetze

  • Best Incorporated Theme – Legatum and NJ van der Merwe

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept